Home › NDC Lookup › Ingredients › Salicylic Acid, Sulfur › 00536-1962-97
Sebex Antidandruff, anti-seborrheic dermatitis, anti-psoriasis Salicylic Acid, Sulfur 20 mg/1000mL; 20 mg/1000mL Shampoo, 118 mL — NDC 00536-1962-97 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Sebex Antidandruff, anti-seborrheic dermatitis, anti-psoriasis Salicylic Acid, Sulfur 20 mg/1000mL; 20 mg/1000mL Shampoo, 118 mL — NDC 0536-1962-97 (Billing 00536-1962-97)

by Rugby Laboratories · 118 mL in 1 BOTTLE

This is a package of 118 mL of Sebex Antidandruff, anti-seborrheic dermatitis, anti-psoriasis Salicylic Acid, Sulfur 20 mg/1000mL; 20 mg/1000mL Shampoo from Rugby Laboratories, marketed since Oct 2012 and currently FDA-listed; retail pharmacies pay about $0.0225 per mL (NADAC). It is this product's only package size.

NDC 00536-1962-97
🏷️ FDA NDC (as labeled) 0536-1962-97 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 0536-1962-97 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0536 labeler · 1962 product · 97 package
Package marketed since
Oct 29, 2012
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
118 mL per package
Barcode (UPC-A, from the NDC)
3 0536196297 5
Medicaid fills, this package
191 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0536-1962-97
Product NDC 0536-1962
11-digit billing NDC 00536196297
NCPDP billing unit ML — per mL (volume)
RxCUI 204638, 210177
UNII O414PZ4LPZ, 70FD1KFU70
Application # M032
SPL Set ID aec81d61-1d28-490f-9654-f66bd4a30ffa
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2012-10-29
Route TOPICAL
Dosage form SHAMPOO
Substance SALICYLIC ACID; SULFUR

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90309902104520
GPI class Sebex
GCN Seq No 005754
GCN 79591
HICL code 002461
Ingredient (HICL) Salicylic Acid/Sulfur
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L5
Therapeutic class — intermediate (HIC2) Keratolytics/Keratoplastics
HIC3 code L5A
Therapeutic class — specific (HIC3) Keratolytics
AHFS code 84:28.00.00
AHFS class Keratolytic Agents
FDB label name SEBEX SHAMPOO
FDB brand name Sebex
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 005754
  • GCN: 79591
  • GPI-14 (Medi-Span): 90309902104520
  • HICL (First Databank): 002461
  • AHFS class code: 84:28.00.00
  • RxCUI (RxNorm): 204638
Why two NDCs? The FDA registers this code as 0536-1962-97 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1962-97. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Preparations containing sulfur class.

Drug family (ATC) Preparations containing sulfur
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name SEBEX SHAMPOO Ingredient Salicylic Acid/Sulfur
🧪 What is this product?

Sebex Antidandruff is an over-the-counter medicated shampoo containing salicylic acid and sulfur. This product is formulated as an OTC monograph drug, meaning it follows FDA's established rules for this category rather than individual approval. Salicylic acid and sulfur are commonly used together in topical products to help reduce scaling, flaking, and irritation associated with conditions like dandruff, seborrheic dermatitis, and psoriasis. The shampoo is applied directly to the scalp and hair during washing.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.023 $2.66 / 118 ml
Medicaid paysCMS SDUD · 12 mo $0.0510 $6.02 / 118 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Sep 2021 Jan 2026 May 2026 Sep 2026 $0.024 $0.020
▲ Up 11% over the last 13 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00536-1962-97 You're viewing this Main listing 118 mL in 1 BOTTLE 2012-10-29 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sebex Antidandruff, anti-seborrheic dermatitis, anti-psoriasis 20 mg/1000mL; 20 mg/1000mLthis 00536-1962-97 Rugby 118 ml $0.022 — Availability likely —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2012
On the market since
Oct 2012
📍
2026
Currently FDA-listed
14 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color yellow
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 2968PHW8QP
    A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
  • UNII 6K8PRP397M
    A plant-derived cleansing agent made from coconut oil. It helps the medicine dissolve evenly and improves how the product spreads or mixes in formulations.
  • UNII F05Q2T2JA0
    Docusate sodium is a stool softener compound that helps medicines dissolve and move through the digestive tract. It acts as a surfactant, reducing surface tension in the intestines, and also serves as a wetting agent in tablet formulations.
  • UNII 8CRQ2TH63M
    Isopropyl palmitate is an oily liquid derived from palm oil. It acts as an emollient and lubricant in medicines, helping soften the skin or improve how the product spreads and flows.
  • UNII 09179OX7TB
    PEG-75 Lanolin is a waxy substance derived from sheep's wool that has been chemically modified to mix easily with water and oil. It acts as an emulsifier and moisturizer in topical formulations, helping blend different ingredients and soften the skin.
  • UNII E40U03LEM0
    A synthetic preservative that kills bacteria and fungi to keep the medicine from spoiling during storage and use.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also stateswater, sodium lauryl sulfate, disodium cocoamphodipropionate, acrylates copolymer, citric acid, PEG-75 lanolin, fragrance, quaternium-15, diethylhexyl sodium sulfosuccinate, isopropyl palmitate, sodium hydroxide.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRugby Laboratories
FDA applicationM032 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedOct 2012
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 9 words ▾

Uses controls the symptoms of: dandruff seborrheic dermatitis psoriasis

⏱️ Dosage and Administration 49 words ▾

Directions SHAKE WELL BEFORE USE wet the scalp or skin and massage in enough shampoo to work up a lather massage for 3-5 minutes and rinse out thoroughly repeat application and rinse thoroughly again for best results, use at least twice a week or as directed by a doctor

⚠️ Warnings 104 words ▾

Warnings For external use only Do not use If condition covers a large area of the body, consult your doctor before using this product this product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed to do so by a doctor When using this product avoid contact with eyes If contact occurs, rinse eyes thoroughly with water Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed. KEEP OUT OF REACH OF CHILDREN. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📦 Storage and Handling 14 words ▾

Other information store at room temperature see container for Lot No. & Exp. date

🧪 Active Ingredient 13 words ▾

Active ingredients Purpose Salicylic Acid, 2% } Sulfur, 2% Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis

🧪 Inactive Ingredients 23 words ▾

Inactive ingredients water, sodium lauryl sulfate, disodium cocoamphodipropionate, acrylates copolymer, citric acid, PEG-75 lanolin, fragrance, quaternium-15, diethylhexyl sodium sulfosuccinate, isopropyl palmitate, sodium hydroxide.

🎯 Purpose 13 words ▾

Active ingredients Purpose Salicylic Acid, 2% } Sulfur, 2% Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis

📄 Do Not Use 42 words ▾

Do not use If condition covers a large area of the body, consult your doctor before using this product this product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed to do so by a doctor

📄 When Using This Product 16 words ▾

When using this product avoid contact with eyes If contact occurs, rinse eyes thoroughly with water

📄 Stop Use and Ask a Doctor If 21 words ▾

Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.

📄 Keep Out of Reach of Children 20 words ▾

KEEP OUT OF REACH OF CHILDREN. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-645-2158

📄 Package Label / Principal Display Panel 33 words ▾

PRINCIPAL DISPLAY PANEL - 118 mL Bottle Label Rugby ® NDC 0536-1962-97 Sebex Medicated Dandruff, Seborrheic Dermatitis, and Psoriasis Shampoo 4 FL OZ (118 mL) Principal Display Panel - 118 mL Bottle Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
191
Units reimbursed last 4 qtrs
23.6K
Gross reimbursed last 4 qtrs
$1.2K
Avg / prescription
$6.30
Avg / unit
$0.0510
Latest quarter Q1 2026
34Rx
Medicaid pays / mL
$0.0510
gross reimbursed
vs
NADAC / mL
$0.0225
acquisition cost
=
Spread
+$0.0285
+127% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
27% FFS 73% MCO
Fee-for-service · 51 Rx Managed care · 140 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: 8,380 units · 64.7 per 100k residents PA New Jersey: 8,850 units · 95.3 per 100k residents NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 6,372 units · 73.1 per 100k residents VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
64.795.3
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New Jersey 95.3 /100k
2 Virginia 73.1 /100k
3 Pennsylvania 64.7 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.